typhus vaccine

{{Short description|Inventor - Rudolf Weigl}}{{Distinguish|typhoid vaccine}}

{{Drugbox

| Verifiedfields = changed

| verifiedrevid = 365989659

| image = Weigl vaccine.jpg

| caption = Typhus vaccine developed by Rudolf Weigl

| type = vaccine

| target = Typhus

| vaccine_type = inactivated

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = none

| CAS_number_Ref = {{cascite|correct|??}}

| CAS_number =

| ATC_prefix = J07

| ATC_suffix = AR01

| PubChem =

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

}}

Typhus vaccines are vaccines developed to protect against typhus.{{cite journal |vauthors=Chattopadhyay S, Richards AL |title=Scrub typhus vaccines: past history and recent developments |journal=Hum Vaccin |volume=3 |issue=3 |pages=73–80 |year=2007 |pmid=17375000 |doi= 10.4161/hv.3.3.4009|url=http://www.landesbioscience.com/journals/hv/abstract.php?id=4009|doi-access=free }} As of 2020 they are not commercially available.{{cite web|title=Epidemic Typhus|url=https://www.cdc.gov/typhus/epidemic/index.html|website=www.cdc.gov|access-date=26 March 2017|language=en-us|date=7 March 2017}}{{cite web|title=Murine Typhus|url=https://www.cdc.gov/typhus/murine/index.html|website=www.cdc.gov|access-date=26 March 2017|language=en-us}}{{cite web|title=Scrub Typhus|url=https://www.cdc.gov/typhus/scrub/index.html|website=www.cdc.gov|access-date=26 March 2017|language=en-us|date=7 March 2017}}

One typhus vaccine consisted of formaldehyde-inactivated Rickettsia prowazekii. Two doses were injected subcutaneously four weeks apart. Booster doses were required every six to twelve months.{{cn|date=September 2022}}